• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钇[90Y]树脂微球选择性内放射治疗联合解剖性肝切除术治疗晚期肝细胞癌:一种潜在的治愈策略。

Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.

机构信息

Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Hainan Cancer Hospital, Haikou, China.

出版信息

Asia Pac J Clin Oncol. 2024 Apr;20(2):319-322. doi: 10.1111/ajco.13900. Epub 2023 Jan 19.

DOI:10.1111/ajco.13900
PMID:36658669
Abstract

About 80% of hepatocellular carcinoma (HCC) patients are in advanced stages and ineligible for curative surgery. Palliative treatments just maintained limited survival, thus an effective downstaging therapy is badly needed. Here we report an initially unresectable patient who underwent radical hepatectomy after successful downstaging with selective internal radiation therapy (SIRT). A 34-year-old man was diagnosed with China Liver Cancer Staging (CNLC) IIIa HCC. Due to insufficient future liver remnant and vascular involvement, the patient was suggested to be unresectable. SIRT with yttrium-90 resin microspheres was given. At three months post-SIRT, a complete response was achieved. The tumor was downstaged to CNLC Ia stage. The patient underwent anatomical hepatectomy 5 months after SIRT. Histopathological examination of the resected specimen showed 4% viable tumor cells inside a necrotic mass. To our knowledge, this is the first case who underwent SIRT with yttrium-90 resin microspheres in China mainland. The success of the downstaging in this case renders a possible cure to be achieved in an initially unresectable patient. In addition, the nearly complete tumor necrosis in the resected specimen indicates a good prognosis post-surgery. This is the first case who underwent SIRT with yttrium-90 resin microspheres in China mainland. SIRT followed by anatomical hepatectomy is a potentially curative strategy for unresectable HCC, which deserves a confirmative trial in the future.

摘要

大约 80%的肝细胞癌 (HCC) 患者处于晚期,不符合根治性手术条件。姑息性治疗只能延长有限的生存时间,因此迫切需要有效的降期治疗。在这里,我们报告了一例最初无法切除的患者,在接受选择性内部放射治疗 (SIRT) 成功降期后接受了根治性肝切除术。一名 34 岁男性被诊断为中国肝癌分期 (CNLC) IIIa HCC。由于未来肝残余量不足和血管受累,建议该患者不可切除。给予钇-90 树脂微球 SIRT。SIRT 后三个月,达到完全缓解。肿瘤降期至 CNLC Ia 期。SIRT 后 5 个月,患者接受解剖性肝切除术。切除标本的组织病理学检查显示 4%的活肿瘤细胞位于坏死肿块内。据我们所知,这是中国大陆首例接受钇-90 树脂微球 SIRT 的病例。该病例的降期成功使最初不可切除的患者有可能获得治愈。此外,切除标本中几乎完全的肿瘤坏死表明术后预后良好。这是中国大陆首例接受钇-90 树脂微球 SIRT 的病例。SIRT 后行解剖性肝切除术是不可切除 HCC 的一种潜在治愈策略,值得未来进行确证性试验。

相似文献

1
Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.钇[90Y]树脂微球选择性内放射治疗联合解剖性肝切除术治疗晚期肝细胞癌:一种潜在的治愈策略。
Asia Pac J Clin Oncol. 2024 Apr;20(2):319-322. doi: 10.1111/ajco.13900. Epub 2023 Jan 19.
2
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.不可切除肝细胞癌的治疗选择,重点是使用钇-90树脂微球的选择性内放射治疗(SIRT)
Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30.
3
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.钇[90Y]树脂微球选择性内放射治疗与索拉非尼治疗局部进展期不可切除肝细胞癌的疗效和安全性比较(SARAH):一项开放标签随机对照 3 期临床试验。
Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26.
4
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.联合选择性内部放射治疗和索拉非尼对晚期肝细胞癌患者生存的影响。
J Hepatol. 2019 Dec;71(6):1164-1174. doi: 10.1016/j.jhep.2019.08.006. Epub 2019 Aug 14.
5
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK.法国、意大利、西班牙和英国不可切除肝细胞癌治疗中 SIR-Spheres 钇[90]树脂微球与酪氨酸激酶抑制剂的成本分析。
J Med Econ. 2020 Jun;23(6):593-602. doi: 10.1080/13696998.2020.1731213. Epub 2020 May 1.
6
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.对钇-90 树脂微球放射性栓塞治疗的反应可能使先前无法切除的肝细胞癌患者获得手术治疗和延长生存的机会。
Eur J Surg Oncol. 2012 Jul;38(7):594-601. doi: 10.1016/j.ejso.2012.02.189. Epub 2012 Mar 21.
7
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes.钇-90选择性内放射治疗后的肝切除术:安全性与疗效
J Gastrointest Cancer. 2020 Mar;51(1):152-158. doi: 10.1007/s12029-019-00221-0.
8
Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.钇-90微球(TheraSphere)用于一名不可切除肝细胞癌患者并导致肝移植:病例报告。
Liver Transpl. 2005 Sep;11(9):1127-31. doi: 10.1002/lt.20514.
9
Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review.结直肠癌肝转移行全身化疗联合钇[90]微球选择性内放射治疗后行肝切除术:系统评价。
Dig Surg. 2019;36(4):273-280. doi: 10.1159/000490111. Epub 2018 Jun 8.
10
The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.《SIR-Spheres 术后研究(P4S)》:先前接受钇 90 树脂微球选择性内部放射治疗的肝切除或肝移植患者的安全性回顾性分析。
Ann Surg Oncol. 2017 Sep;24(9):2465-2473. doi: 10.1245/s10434-017-5950-z. Epub 2017 Jun 26.

引用本文的文献

1
Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma.免疫检查点抑制剂在治疗晚期肝细胞癌中的研究进展。
Front Immunol. 2024 Aug 9;15:1455716. doi: 10.3389/fimmu.2024.1455716. eCollection 2024.